3Rosenbery M, Correa Rottar R. Pathogenesis and Risk Factor for Diabetic Nephropat.Kidney Int,2003,17(46):272
4UK Prospective Diabetes Study Group. Tight blood pressure and risk of macrovascular and microvascular complication in type 2 diabetes.BMJ,1998,28(317):703
7Nakamara T, Ushiyama C,Osada S, et al. Pioglitazons reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria.Metabolism,2001,50(10):1193
8Rajiv A. Add-on angiotension receptor blockade with maximized ACE inhibition.Kidney Int, 2001 ,59(2): 282
9Striker LJ, Striker Ge, Guo J, et al. Administration of AGEs in zvixo Induces Extracellular Matrix Gene Express.Nephrol Dial Transplant, 2000,11(5):62
10American Diabetes Association. Management of dyslipidemia in adults with diabetes(position statement). Diabetes Care,2002,25(S):74
